References
- Aulthouse AL, Hitt DC. 1994. The teratogenic effects of valproic acid in human chondrogenesis in vitro. Teratology 49:208–217.
- Bell AD, Gerlis LM, Variend S. 1986. Persistent right umbilical vein–case report and review of literature. International Journal of Cardiology 10:167–176.
- Cetinkaya M, Ozkan H, Köksal N. 2008. Unilateral radius aplasia due to lamotrigine and oxcarbazepine use in pregnancy. Journal of Maternal-Fetal and Neonatal Medicine 21:927–930.
- Jentink J, Dolk H, Loane MA .; EUROCAT Antiepileptic Study Working Group. 2010. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. British Medical Journal 341:6581.
- Montouris G. 2005. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Current Medical Research and Opinion 21: 693–701.
- Moore SJ, Turnpenny P, Quinn A . 2000. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 37:489–497.
- Tomson T, Battino D, Bonizzoni E .; for the EURAP study group. 2011. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurology 10:609–617.
- Van Den Berg DJ, Francke U. 1993. Roberts syndrome: a review of 100 cases and a new rating system for severity. American Journal of Medical Genetics 47:1104–1112.
- Verloes A, Frikiche A, Gremillet C . 1990. Proximal phocomelia and radial ray aplasia in fetal valproic syndrome. European Journal of Pediatrics 149:266–267.